Colonoscopy Every Three Years Indicated For Those With Family History Of Polyps
Men With Low PSA Scores May Not Need Annual Tests, Data From PLCO Trial Suggests
Gleevec Better Than Interferon For Newly Diagnosed CML
Two-Drug Combination Extends Survival Of Mesothelioma
Preventive Surgery Cuts Risk Of Breast, Ovarian Cancers
Two-Month Survival Benefit For Some NSCLC Patients
Cancer Cases To Double By 2050, Annual Report Says
Women Radiated For Wilms’ At Risk For Complications In Pregnancy, Study Finds
St. John’s Wort Not Indicated For Patients On Irinotecan
Large Pregnancy Weight Gain Raises Risk For Breast Cancer
Clinical Trials Approved Last Month By NCI’s CTEP
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest
- Scaling excellence: How City of Hope is transforming cancer care delivery
- She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
